Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

What's Going On With Incannex Healthcare's Stock Today?

Incannex Healthcare Ltd (NASDAQ:IXHL) is soaring Tuesday on abnormally-high volume. The stock has been extremely volatile since the company released a preliminary analysis of data from its phase 2 clinical trial investigating its novel cannabinoid combination product, IHL-42X, for the treatment of obstructive sleep apnoea.

Related Link: Incannex Clinical Trial Shows Notable Reduction In The Apnoea Hypopnoea Index With Novel Cannabinoid Product

Incannex's average session volume is 5,768 over a 100-day period, according to data from Benzinga Pro. Tuesday's trading volume has already exceeded 325,000 at publication time.

Incannex is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs.

IXHL Price Action: Icannex shares are making new 52-week highs after being halted several times during Tuesday's trading session.

The stock was up 210% at $71 at time of publication.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.